NeuroLab AI will launch its token sale on September 16 at Bio Protocol

Decentralized Scientific Finance Layer Bio Protocol announced that NeuroLab AI, developed by NootropicsDAO, will launch its Ignition Sale on September 16 at 14:00 (UTC) on Bio Protocol. The token for sale is NDT, lasting for two weeks, and participation requires staking USDC, with the option to pair with BioXP. Bio Protocol stated that NeuroLab AI is used to predict the potential effects of compounds on the brain and associates molecular interactions with cognitive effects, aiming to assist researchers in deciding the next laboratory test subjects. The project claims its knowledge graph has compiled over 150,000 entries and over 8 million associations.

The initial fundraising scale is $200,000, with a starting fully diluted valuation of $3 million and initial project funds of $100,000. Participant shares are 100% unlocked upon receipt, with no lock-up period and no linear release. veBIO holders are allocated 20%, which can be claimed at any time; any unreleased portion becomes void upon claiming, with 20% released at TGE, and the remainder released linearly over 6 months; the ignition sale allocation is 6.67%. Users without BioXP can obtain it by staking BIO or ecosystem tokens, or by consuming BIO for instant minting.